ArticleProceedings of the National Academy of Sciences of the United States of America2019

Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma.

Laurene S Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.